A comparative study of once versus twice daily treatment of superficial dermatophyte and yeast infections with tioconazole (1%) cream.

Author: GibbsD L, KashinP, PhyfferoenM C

Paper Details 
Original Abstract of the Article :
Two open, multicentre studies were performed to evaluate the efficacy of 1% tioconazole cream (Trosyd, Pfizer) as a once daily treatment for patients with common superficial dermatophyte and yeast infections (t. pedis, t. versicolor, t. corporis, t. cruris, candidiasis). In Study I, forty-eight pati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/030006058501300203

データ提供:米国国立医学図書館(NLM)

Efficacy of Tioconazole Cream for Superficial Dermatophyte and Yeast Infections

The field of dermatology is a vast and ever-evolving desert, where researchers strive to develop effective treatments for a wide range of skin conditions. This study investigates the efficacy of tioconazole cream, an antifungal medication, in treating common superficial dermatophyte and yeast infections. The authors compare the effectiveness of once-daily versus twice-daily treatment regimens, evaluating the clinical and mycological outcomes.

Tioconazole Cream: Effective for Superficial Dermatophyte and Yeast Infections

This multicenter study demonstrates the efficacy of tioconazole cream in treating superficial dermatophyte and yeast infections. The study found that both once-daily and twice-daily treatment regimens achieved high rates of clinical and mycological cure, with no statistically significant difference in efficacy between the two regimens. These findings suggest that tioconazole cream is an effective treatment option for these common skin infections.

Optimizing Antifungal Therapy for Superficial Infections

This research provides valuable insights into the optimization of antifungal therapy for superficial dermatophyte and yeast infections. The study's findings suggest that a once-daily regimen of tioconazole cream may be sufficient to achieve optimal therapeutic outcomes, potentially improving patient convenience and adherence. As we continue to explore the desert of dermatological research, we are gaining valuable insights into the mechanisms of antifungal action and developing innovative treatments to combat these common skin infections.

Dr. Camel's Conclusion

This study offers a refreshing oasis in the desert of dermatological research, demonstrating the effectiveness of tioconazole cream in treating superficial dermatophyte and yeast infections. The findings suggest that a once-daily regimen may be sufficient for optimal outcomes, offering a potentially more convenient and patient-friendly treatment option. As we continue to journey through this desert of knowledge, we are gaining valuable insights into the mechanisms of antifungal action and developing innovative therapies to combat these common skin infections.

Date :
  1. Date Completed 1985-06-26
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

3888731

DOI: Digital Object Identifier

10.1177/030006058501300203

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.